| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $14.99B | +110.4% |
| Cost of Revenue | $12.93B | +121.3% |
| Gross Profit | $2.06B | +60.7% |
| R&D Expense | $463.5M | +50.9% |
| SG&A Expense | $197.3M | +98.2% |
| Operating Income | $1.21B | +59.1% |
| Pre-tax Income | $1.21B | +61.0% |
| Income Tax | $63.3M | -42.8% |
| Net Income | $1.15B |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.67B | +279.1% |
| Accounts Receivable | $2.74B | +138.4% |
| Inventory | $4.33B | +199.7% |
| Current Assets | $8.93B | +180.9% |
| Total Assets | $9.83B | +167.4% |
| Current Liabilities | $2.35B | +70.6% |
| Total Liabilities | $4.41B | +158.9% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.49B | -474.6% |
| Capital Expenditures | $124.3M | +237.8% |
| Investing Cash Flow | -$194.2M | -391.9% |
| Financing Cash Flow | $3.91B | +972.6% |
| Free Cash Flow | -$2.61B | -516.4% |
| +80.1% |
| EPS (Basic) | $2.07 | -82.9% |
| EPS (Diluted) | $1.92 | -83.2% |
| Stockholders' Equity |
| $5.42B |
| +174.7% |